HomeSHRX • CVE
add
Sharp Therapeutics Corp
Previous close
$1.85
Year range
$0.80 - $2.28
Market cap
55.39M CAD
Avg Volume
373.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 391.03K | -30.14% |
Net income | -112.74K | 88.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -387.28K | 29.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.48M | 824.64% |
Total assets | 4.55M | 194.48% |
Total liabilities | 1.97M | -84.89% |
Total equity | 2.58M | — |
Shares outstanding | 29.94M | — |
Price to book | 20.56 | — |
Return on assets | -21.47% | — |
Return on capital | -25.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -112.74K | 88.00% |
Cash from operations | -1.18M | -154.15% |
Cash from investing | 2.55K | — |
Cash from financing | 2.80M | 460.60% |
Net change in cash | 1.63M | 4,616.63% |
Free cash flow | -243.58K | 29.60% |
About
Founded
2021
Headquarters
Website
